Notable insider buying and selling activity across public companies.
Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.
4,728 total articles
A consortium of American Industrial Partners-related entities reported the sale of 2,545,432 shares of V2X Inc. (VVX) common stock on March 12, 2026, at $68.21 per share, a transaction that generated roughly $173.6 million. The disclosure follows recent volatility in VVX shares and comes amid a quarter in which the company reported earnings and rev…
On Semiconductor executive Sudhir Gopalswamy sold 6,114 shares on March 13, 2026, for $58.67 per share, generating proceeds of $358,708. The sale, recorded on a Form 4, left Gopalswamy with 173,943 shares. Separately, corporate notices and equity actions were reported at Ascendis Pharma, Onsemi, KB Financial Group, Royal Bank of Canada and Webuy Gl…
Kevin Patrick Marchetti, Co-Executive Chairman of Lineage, Inc. (NASDAQ: LINE), purchased 13,300 shares on March 12, 2026 for $498,699. The buy brings his direct stake to 113,690 shares while he also holds substantial indirect positions. The acquisition comes as Lineage reported steady fourth-quarter 2025 revenue and a modest EPS, and as at least o…
Thomas R. Donahue, Federated Hermes' vice president, chief financial officer and treasurer, sold 30,000 shares of Class B common stock on March 13, 2026, in a transaction valued at $1.71 million, according to a recent SEC Form 4 filing. The company also reported fourth-quarter 2025 results that beat estimates while facing legal action in the High C…
Joseph Paul C, Akamai Technologies Inc's Executive Vice President - Global Sales, executed three sales totaling 4,990 shares on March 16, 2026 for approximately $531256 under a Rule 10b5-1 trading plan. The transactions left him with 34,533 directly held shares and 165.196 indirectly held shares via a 401(k). The insider move coincides with Akamai …
Absci Corp's Chief Innovation Officer Andreas Busch purchased 100,000 shares on March 12, 2026, spending $229,000 at $2.29 per share. The insider buy leaves Busch with 421,446 shares directly. The transaction comes as the stock trades near its 52-week low and follows recent clinical data that prompted a program pause and a reduction in analyst opti…
Akamai Technologies reported that Executive Vice President and General Counsel Ahola Aaron sold 4,500 shares of common stock on March 16, 2026, for a total of $478,216 at prices between $106.2463 and $106.37. Following the sale, Ahola retains direct ownership of 29,716 shares, including deferred compensation and trust holdings, plus an indirect hol…
Root, Inc. Chief Administrative Officer Jonathan Allison sold 3,900 Class A shares on March 12, 2026, for $43.61 each, totaling $170,079. The sale was made under a pre-arranged 10b5-1 plan and follows the insurer's Q4 2025 results showing strong revenue growth but a slight decline in net income due to higher operating expenses. Keefe, Bruyette & Wo…
EyePoint Inc. President and CEO Jay S. Duker purchased 1,500 shares of common stock on March 16, 2026, spending $19,723 at an average price of $13.1492 per share. The purchase follows a 16% drop in the prior week while the stock remains up more than 102% over the last 12 months. EyePoint reported weak fourth-quarter 2025 results with a wider-than-e…
Ultralife Corp President and CEO Michael Edward Manna bought 2,000 shares of the company's common stock on March 12, 2026, spending $12,024 across two transactions. The purchases occurred after the stock gained 23% over the prior week and amid a quarterly report that beat on EPS but missed on revenue. InvestingPro lists Ultralife among its Most Und…
Lori Winkler, senior vice president and chief human resources officer at Zimmer Biomet Holdings, sold 2,650 shares on March 12, 2026, generating proceeds of $250,849. The executive retains 10,224 shares after the sale. The transaction arrives amid a fourth-quarter earnings beat, a guarded outlook for 2026, and fresh coverage from William Blair assi…
NeuroOne Medical Technologies (NMTC) Business Development Director Mark Christianson sold 917 shares of company stock on March 12 and 13, 2026, receiving approximately $733. The transactions left him with 214,283 shares. The company reported a Q1 fiscal 2026 net loss of $1.4 million on revenue of $2.9 million, slightly above expectations. Investing…
Pamela W. Montgomery, Nutex Health Inc.'s Chief Legal Officer-Healthcare, bought 79 shares of the company's common stock on March 13, 2026, spending $7,020 at $88.87 per share. The purchase follows a near 10% slide over the prior week and comes amid a 41.1% year-over-year drop in Nutex Health's fourth-quarter 2025 revenue. Montgomery also reported …
Carol A. Schneeberger, a director at Peoples Bancorp Inc (NASDAQ: PEBO), filed a Form 4 showing the sale of 1,000 shares on March 9, 2026, for $31.41 each, totaling $31,410. The bank reported higher net income and net interest income for the fourth quarter of 2025 versus the prior year, recorded a slight revenue shortfall to consensus, and beat on …
Ann D. Janssen, Executive Vice President and Chief Financial Officer of EOG Resources (EOG), conducted multiple equity transactions on March 12, 2026, including the sale of common stock and the exercise of stock appreciation rights. The combined activity involved disposals and acquisitions worth more than $1 million and occurred while the company's…
Axt Inc director Jesse Chen sold 14,086 shares of common stock across March 12 and 13, 2026, for approximately $700,039. The sales came as the stock traded near its 52-week high and after the company reduced fourth-quarter revenue guidance because of restricted export permits for indium phosphide from China’s Ministry of Commerce. Several analysts …
Robert Bruce Atwell, a director of Nicolet Bankshares Inc (NASDAQ:NIC), exercised options to acquire 10,000 shares and sold a portion of his stake on March 12, 2026. The transactions included the sale of 3,309 shares valued at $495,759 and an additional disposition of 6,691 shares at $150.28 per share. The moves coincide with Nicolet’s completed me…
A Form 4 filing shows AXT Inc. CEO Morris S. Young sold 37,905 shares on March 13, 2026, at a weighted average price of $51.1283 for a total of $1.93 million. The trade occurred as the stock traded close to its 52-week high after a 2,614% year-over-year gain. Separately, AXT reduced its fourth-quarter revenue outlook amid export-permit restrictions…
AXT Inc.'s Chief Financial Officer, Gary L. Fischer, executed two block sales on March 12 and March 13, 2026, disposing of a total of 88, (please see article for full total) shares for roughly $4.5 million. The transactions occurred as the company narrowed its fourth-quarter revenue outlook due to fewer export permits for indium phosphide substrat…
Tyler Technologies director Glenn A. Carter sold 1,624 shares on March 12, 2026, at $349.14 each for $567,003 and exercised options to acquire additional shares the same day. The stock has fallen from a 52-week high of $621 to trade near $350, and the company has announced a $200 million buyback under a larger repurchase authorization amid fourth-q…
Elizabeth Loveman, senior vice president and controller at NACCO Industries Inc (NYSE: NC), sold 1,662 shares of Class A common stock on March 13, 2026, in a Form 4 filing. The sale came as the company reported a fourth-quarter 2025 net loss tied to one-time pension settlement charges, even as revenue rose 5% year-over-year to $66.8 million. Invest…
ChoiceOne Financial Services Inc. (NASDAQ: COFS) Secretary Adom Greenland purchased 500 shares of the company's common stock on March 12, 2026, in a transaction totaling $13,700. The trade was disclosed in a Form 4 filed with the SEC on March 16, 2026. The shares were acquired at an average price of $27.40, and the stock is trading close to that le…
Avidbank Holdings director Mike Rosinus sold 7,953 shares on March 13, 2026, at $27.49 per share, netting $218,627. The company recently reported mixed fourth-quarter fiscal 2025 results, and analysts foresee a 2026 EPS turnaround even as some research flags the stock as overvalued at present levels.
Director Eichten Estia J. sold 2,000 shares of Vicor Corp (VICR) common stock on March 13, 2026 at $174.00 per share, resulting in a transaction value of $348,000. Following the sale, the director retains direct ownership of 188,838 shares. The disposition was executed under a Rule 10b5-1 trading plan adopted on December 11, 2025. InvestingPro anal…
Avidbank Holdings director Mike Rosinus sold 19,318 shares on March 10, 2026, for $28.28 each, a transaction valued at $546,313. Following the sale Rosinus holds shares both directly and indirectly. Analysts expect net income growth and potential profitability this year despite a recent loss over the trailing twelve months and a fourth-quarter EPS …
